Advancing new drug therapies for unmet medical needs

Developing novel drug therapies for unmet medical needs 2017-12-10T16:33:34+00:00

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

ASX: Dimerix rights issue discussion

Dimerix announced last week that it would offer shareholders the opportunity to participate an Entitlement Offer to raise up to $5.5m. [...]

Entitlement Offer Booklet

Read the Entitlement Offer Booklet here.

Click here to view analyst coverage
Click here to view our corporate fact sheet
Click here to view our corporate presentation